Maud Jost

University of Liège

Papers

1

Total Citations

121

H-Index

1

About

Maud Jost is a leading researcher in ocular angiogenesis, with a particular focus on the molecular mechanisms driving blinding eye diseases. Her landmark 2002 study, "Matrix Metalloproteinase-9 Contributes to Choroidal Neovascularization," has garnered over 120 citations and established a critical link between the enzyme MMP-9 and the pathological blood vessel growth underlying age-related macular degeneration. This work provided foundational evidence that MMP-9 is not merely a bystander but an active contributor to choroidal neovascularization, opening new avenues for targeted therapeutic interventions. Jost’s research integrates molecular biology, vascular biology, and ophthalmology, offering insights that bridge basic science and clinical application. Her contributions have been instrumental in advancing our understanding of how extracellular matrix remodeling drives disease progression, influencing subsequent studies on anti-angiogenic treatments. For students and researchers, Jost’s work exemplifies how a focused, mechanistic investigation can illuminate a pathway from enzyme to pathology, ultimately guiding the development of therapies that preserve vision.

Research Focus

Key Achievements

1
H-Index
1
Papers
121
Total Citations
121
Avg Citations/Paper
🏆 Most Cited Paper
Matrix Metalloproteinase-9 Contributes to Choroidal Neovascularization
121 citations · 2002
📈 Most Prolific Year: 2002 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: University of Liège

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago